|Bioquell plc -- USA Stock|| |
USD 3.5 0.00 0.00%
Non-Executive Chairman of the Board
Mr. Ian Roy Johnson was appointed as NonExecutive Chairman of the Board of the Company, effective 10 June, 2016. Mr Johnson has spent his career working in a number of Life Sciences companies and is currently nonexecutive chairman of Cyprotex PLC and was formerly nonexecutive chairman of Celsis International Group as well as a nonexecutive director of MyCelx Technologies Corporationrationration.
Age: 62 Chairman Since 2016
44 1264 835 900 http://www.bioquellplc.com
The company has return on total asset (ROA)
of 5.32 %
which means that it generated profit of $5.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 5.16 %
meaning that it generated $5.16 on every $100 dollars invested by stockholders.
Bioquell PLC designs, manufactures, and supplies biodecontamination and containment equipment, and related solutions and services to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in Andover, SP TS and employs 226 people.